FDA Nixes Weight Loss Pill

Newspaper Columns, Pharmacy Q&A July 20, 2007

Q. Months ago I heard about a new prescription drug for weight loss that also lowered cholesterol and blood sugar levels. It was awaiting approval. Has it become available?

A. The drug is rimonabant. Although it is now available in Europe, a panel of experts recommended to the FDA that it not be approved due to an increased risk of depression or suicidal thoughts.

Share Your Experiences

Do you have personal experiences related to this article? If so, we want to hear from you! Let us know your thoughts:

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)

Name (or initials):

Email address (required, will not be displayed on site):

Web site address (optional):

Remember the information above? (If you check this box, the next time you post a comment you will not need to re-enter your name and email address)

Note: If you make a factual claim (for example, about a person, group or product) be sure to include a link to a reference. This will help other readers learn more. Thanks!

Comments:

Joe Graedon is a pharmacologist. Teresa Graedon holds a doctorate in medical anthropology and is a nutrition expert. Their syndicated radio show can be heard on public radio. In their column, Joe and Teresa Graedon answer letters from readers. Write to them in care of this newspaper or e-mail them via their Web site: www.PeoplesPharmacy.com.

The People's Pharmacy® with Joe and Terry Graedon

Search